Metraipolis › archive › dc_40e70ae1be30

Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both… — Europe PMC PMID:34613993

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34613993
DOI
10.1371/journal.pntd.0009779
License (as archived)
CC0-1.0
Archived
2026-11-02T13:10:51.990Z
SHA-256 of the archived text
ffd4950e09bb16efc971945d34c9d4ecde522cb4de17992bb1d585cdbac915e0
Stable URL of this page
https://metraipolis.com/documento/dc_40e70ae1be30

How to cite

Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both… — Europe PMC PMID:34613993 — Europe PMC (en), https://europepmc.org/article/MED/34613993 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_40e70ae1be30 (Metraipolis archive dc_40e70ae1be30, sha256 ffd4950e09bb16efc971945d34c9d4ecde522cb4de17992bb1d585cdbac915e0)
BibTeX
@misc{dc40e70ae1be30,
  title = {Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both… — Europe PMC PMID:34613993},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34613993},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_40e70ae1be30; sha256 ffd4950e09bb16efc971945d34c9d4ecde522cb4de17992bb1d585cdbac915e0},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34613993. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Introduction: The clinical significance of Blastocystis sp. and Dientamoeba fragilis in patients with gastrointestinal symptoms is a controversial issue. Since the pathogenicity of these protists has not been fully elucidated, testing for these organisms is not routinely pursued by most laboratories and clinicians. Thus, the prevalence of these organisms and the subtypes of Blastocystis sp. in human patients in Turkey are not well characterized. This study aimed to determine the prevalence of Blastocystis sp. and D. fragilis in the diarrheic stool samples of immunodeficient and immunocompetent patients using conventional and molecular methods and to identify Blastocystis sp. subtypes using next generation sequencing. Material and methods: Individual stool specimens were collected from 245 immunodeficient and 193 immunocompetent diarrheic patients between March 2017 and December 2019 at the Gazi University Training and Research Hospital in Ankara, Turkey. Samples were screened for Blastocystis sp. and D. fragilis by conventional and molecular methods. Molecular detection of both protists was achieved by separate qPCRs targeting a partial fragment of the SSU rRNA gene. Next generation sequencing was used to identify Blastocystis sp. subtypes. Results: The prevalence of Blastocystis sp. and D. fragilis was 16.7% and 11.9%, respectively as measured by qPCR. The prevalence of Blastocystis sp. and D. fragilis was lower in immunodeficient patients (12.7% and 10.6%, respectively) compared to immunocompetent patients (21.8% and 13.5%, respectively). Five Blastocystis sp. subtypes were identified and the following subtype distribution was observed: ST3 54.4% (n = 37), ST2 16.2% (n = 11), ST1 4.4% (n = 3), ST6 2.9% (n = 2), ST4 1.5% (n = 1), ST2/ST3 11.8% (n = 8) and ST1/ST3 8.8% (n = 6). There was no statistically significant difference in the distribution of Blastocystis sp. subtypes between immunocompetent and immunodeficient patients. Conclusion and recommendation: Our findings demonstrated that Blastocystis sp. and D. fragilis are commonly present in immunocompetent and immunodeficient patients with diarrhea. This study is the first to use next generation sequencing to address the presence of Blastocystis sp. mixed subtypes and intra-subtype variability in clinical samples in Turkey.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2021 (prima pubblicazione 2021-10-06).
Identificativi: PMID 34613993 · PMCID PMC8494357 · DOI 10.1371/journal.pntd.0009779.
Pagina: https://europepmc.org/article/MED/34613993 — https://doi.org/10.1371/journal.pntd.0009779. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-02T13:02:58.557Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.